SHL Telemedicine Ltd. (SHLT)
2.35
-0.15 (-6.00%)
At close: Mar 24, 2025, 3:57 PM
-6.00% (1D)
| Bid | 2.25 |
| Market Cap | 38.52M |
| Revenue (ttm) | 55M |
| Net Income (ttm) | -8.69M |
| EPS (ttm) | -0.53 |
| PE Ratio (ttm) | -4.43 |
| Forward PE | -10.75 |
| Analyst | Buy |
| Ask | 2.66 |
| Volume | 5,051 |
| Avg. Volume (20D) | 4,615 |
| Open | 2.54 |
| Previous Close | 2.50 |
| Day's Range | 2.23 - 2.54 |
| 52-Week Range | 2.03 - 7.96 |
| Beta | 0.45 |
About SHLT
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device f...
Sector Healthcare
IPO Date Apr 3, 2023
Employees 583
Stock Exchange NASDAQ
Ticker Symbol SHLT
Website https://www.shl-telemedicine.com
Analyst Forecast
According to 1 analyst ratings, the average rating for SHLT stock is "Buy." The 12-month stock price forecast is $11, which is an increase of 368.09% from the latest price.
Stock Forecasts